Valentin Stonik

Prof. Valentin Stonik


Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
VSValentin Stonik
Valentin Stonik
SESvetlana Ermakova
Svetlana Ermakova
TZTatyana N. Zvyagintseva
Tatyana N. Zvyagintseva
Valentin StonikValentin Stonik
Valentin Stonik
Many marine-derived polysaccharides and their analogues have been reported as showing anticancer and cancer preventive properties. These compounds demonstrate interesting activities and special modes of action, differing from each other in both structure and toxicity profile. Herein, literature data concerning anticancer and cancer preventive marine polysaccharides are reviewed. The structural diversity, the biological activities, and the molecular mechanisms of their action are discussed.

1 June 2007 in Journal of Natural Products
Verified
Journal Article
Closed access
OSOlga F. Smetanina
Olga F. Smetanina
AKAnatoly I. Kalinovsky
Anatoly I. Kalinovsky
YKYuliya V. Khudyakova
Yuliya V. Khudyakova
MPMikhail V. Pivkin
Mikhail V. Pivkin
PDPavel S. Dmitrenok
Pavel S. Dmitrenok
TKTatyana A. Kuznetsova
Tatyana A. Kuznetsova

1 April 2010 in Toxicon
Verified
Journal Article
Closed access
VSValentin Stonik
Valentin Stonik
Sergey DyshlovoySergey Dyshlovoy
Sergey Dyshlovoy
MMMargarita Monastyrnaya
Margarita Monastyrnaya
LSLarisa Shubina
Larisa Shubina
Elena LeychenkoElena Leychenko
Elena Leychenko
Valentin StonikValentin Stonik
Valentin Stonik

20 January 2009 in FEBS Letters
Verified
Journal Article
Closed access
JJJun-O Jin
Jun-O Jin
VSValeria V. Shastina
Valeria V. Shastina
SSSung-Won Shin
Sung-Won Shin
QXQi Xu
Qi Xu
JPJoo-In Park
Joo-In Park
JKJong-Young Kwak
Jong-Young Kwak

21 February 2008 in Journal of Natural Products
Verified
Journal Article
Closed access
ASAlexandra S. Silchenko
Alexandra S. Silchenko
SASergey A. Avilov
Sergey A. Avilov
VKVladimir I. Kalinin
Vladimir I. Kalinin
AKAnatoly I. Kalinovsky
Anatoly I. Kalinovsky
PDPavel S. Dmitrenok
Pavel S. Dmitrenok
Valentin StonikValentin Stonik
Valentin Stonik

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Sergey DyshlovoySergey Dyshlovoy
Sergey Dyshlovoy
VSValentin Stonik
Valentin Stonik
LSLarisa K. Shubina
Larisa K. Shubina
AKAlexandra S. Kuzmich
Alexandra S. Kuzmich
CBCarsten Bokemeyer
Carsten Bokemeyer
Friedemann HoneckerFriedemann Honecker
Friedemann Honecker
Aaptamine (8,9-dimethoxy-1H-benzo[de][1,6]naphthyridine) is a marine natural compound possessing antioxidative, antimicrobial, antifungal, and antiretroviral activity. Earlier, we have found that aaptamine and its derivatives demonstrate equal anticancer effects against the human germ cell cancer cell lines NT2 and NT2-R and cause some changes in the proteome of these cells. In order to explore further the mechanism of action of aaptamine and its derivatives, we studied the effects of aaptamine (1), demethyl(oxy)aaptamine (2), and isoaaptamine (3) on human cancer cell lines and on AP-1-, NF-κB-, and p53-dependent transcriptional activity in murine JB6 Cl41 cells. We showed that compounds1–3demonstrate anticancer activity in THP-1, HeLa, SNU-C4, SK-MEL-28, and MDA-MB-231 human cancer cell lines. Additionally, all compounds were found to prevent EGF-induced neoplastic transformation of murine JB6 Cl41 cells. Nuclear factors AP-1, NF-κB, and p53 are involved in the cellular response to high and nontoxic concentrations of aaptamine alkaloids1–3. Furthermore, inhibition of EGF-induced JB6 cell transformation, which is exerted by the compounds1–3at low nontoxic concentrations of 0.7–2.1 μM, cannot be explained by activation of AP-1 and NF-κB.